| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0042 | 0.9 |